Global Radiation Oncology Market Report 2022 to 2028: Expanding Public-Private Funding For Cancer Research Drives Growth - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Radiation Oncology Market Size, Share & Industry Trends Analysis Report By Application, By Type (External Beam Radiation Therapy and Internal Beam Radiation Therapy), By Regional Outlook and Forecast, 2022 - 2028" report has been added to ResearchAndMarkets.com's offering.

The Global Radiation Oncology Market size is expected to reach $12.8 billion by 2028, rising at a market growth of 8.5% CAGR during the forecast period.

A multidisciplinary approach to treating cancer must include the medical specialty of radiation oncology (radiotherapy/radiotherapy). It makes use of high-energy x-rays (photons), which are typically delivered by a linear accelerator. These non-invasive, painless therapeutic x-rays are used to treat a variety of malignancies.

A multidisciplinary team composed of radiation oncologists, nurses, radiation therapists, and medical physicists will discuss radiation therapy as a treatment option, assess users, plan and deliver users' treatments, and assist users with any side effects experienced.

The linear accelerator is housed within a cancer center. Radiation therapy, often known as radiation, has acquired recognition as a highly effective cancer treatment option for reducing cancer-related morbidity and mortality. The desire for technologically advanced treatment options is growing, which is driving the market for radiation oncology.

Accurate tumor localization during oncology has been made possible by the introduction of cutting-edge technology. The effectiveness of radiation oncology has increased due to the use of diagnostic imaging. Treatment approaches include stereotactic radiosurgery, volumetric-modulated arc therapy, 3D high-dose-rate brachytherapy, and 3D conformal radiation have all grown in popularity.

Additionally, the planning of diagnosis, staging, and oncology is becoming more and more dependent on enhanced imaging modalities. Tumor targeting developments in radiation oncology have paved the way for individualized care due to the field's continual breakthroughs. The market for radiation oncology is anticipated to be driven by technical developments that increase the efficacy and safety of treatments.

4D radiation, which combines 4D imaging with radiotherapy, enables accurate tumor size, shape, area, and volume measurements as well as real-time tumor tracking. With this combination, medical professionals can still administer a conformal dose while compensating for organ, tumor, or patient movement.

Market Growth Factors

Radiotherapy Education Program

The advantages of radiation treatments have motivated numerous activities, including conferences and symposia, in recent years. At such gatherings, a bigger emphasis is placed on raising awareness of the advantages and therapeutic benefits that radiation provides for a variety of cancers. For instance, Portugal will host the 6th Cancer World Congress in September 2022. The sixth Cancer World Congress will focus on "Personalized Cancer Diagnosis and Therapy" in 2022.

Expanding Public-Private Funding For Cancer Research

The second-leading cause of death, cancer, is responsible for a significant fraction of all fatalities. Wealthy countries have a substantially higher cancer rate than developing ones. It is anticipated that recognized risk factors will be increasingly prominent in these developing nations due to population growth, aging, and an increase in known risk factors. Lung cancer is the leading cause of cancer-related death in men only in industrialized countries, while breast cancer is the leading cause of cancer death in developing countries.

Market Restraining Factors

Lack Of Qualified Radiologists And Oncologists

To improve the precision and focus of the equipment and techniques used in radiotherapy, there are ongoing technological developments. However, as a clinical modality, radiation, high standards can only be attained and upheld by full-time professionals. Thus, it is anticipated that a lack of technical know-how and a paucity of skilled workers is expected to hinder the introduction of modern radiation. Due to a lack of qualified and trained people, many cancer patients are denied access to effective and cutting-edge radiotherapy techniques.

Scope of the Study

Market Segments Covered in the Report:

By Application

• Breast Cancer
• Gynecological Cancer
• Colorectal Cancer
• Lung Cancer
• Prostate Cancer
• Head & Neck Cancer
• Gynecological Cancer
• Others

By Type

• External Beam Radiation Therapy
• Internal Beam Radiation Therapy

By Geography

• North America
• US
• Canada
• Mexico
• Rest of North America
• Europe
• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific
• LAMEA
• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Becton, Dickinson and Company
• Varian Medical Systems, Inc.
• Ion Beam Applications SA
• Elekta AB
• Accuray Incorporated
• Nordion Inc. (Sotera Health LLC)
• Isoray Inc.
• Mevion Medical Systems, Inc.
• Provision Healthcare
• Panacea Medical Technologies Pvt. Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/1n2k4w